All In Biotech

Free tool

FAERS Monitor: Erzofri

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216352 or its brand name (Erzofri, Paliperidone Palmitate). Reports on generic versions are filed under their own applications.

Reports

3,421

Serious

3,270

96% of reports

Hospitalization

1,572

Death reported

484

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hospitalisation429
  • drug ineffective329
  • schizophrenia269
  • death256
  • suicide attempt253
  • off label use252
  • dyskinesia232
  • sedation223
  • sexual dysfunction210
  • dystonia201
  • condition aggravated199
  • blood glucose increased195
  • disturbance in social behaviour192
  • metabolic disorder191
  • anosognosia188

Reports by year received

View as table
YearReports
20062
20071
20081
20095
20107
201115
201276
201374
201449
201533
201646
201773
2018120
2019173
2020136
2021195
2022650
2023551
2024482
2025393
2026339

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,738 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anosognosiaSignal1881994.51697.9281,407
disturbance in social behaviourSignal192545.5472.495,358
metabolic disorderSignal191209.1181.738,058
schizophreniaSignal269139.2123.935,970
sexual dysfunctionSignal210112.198.222,613
dystoniaSignal20164.456.212,359
sedationSignal22352.846.511,197
dyskinesiaSignal23235.331.27,667
suicide attemptSignal25325.822.95,988
hospitalisationSignal42917.215.86,564
blood glucose increasedSignal1956.45.6884
condition aggravatedSignal1994.03.5456
death2561.81.699
off label use2521.81.687
drug ineffective3291.51.465

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.